PA
EGAN icon

PharVision Advisers’s eGain EGAN Stock Holding History

PharVision Advisers’s Portfolio EGAN Stock Details EGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.2K Sell
10,550
-8,825
-46% -$85.2K 0.84% 61
2025
Q4 		$199K Buy
+19,375
New +$232K 0.1% 562

Other funds holding EGAN

OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's EGAN Position: Q1 2026 in Review

PharVision Advisers reduced its eGain (EGAN) stake by 46% in Q1 2026, selling an estimated $85.2K and leaving 10,550 shares worth $83.2K. The position accounts for 0.84% of the portfolio, ranked #61.

PharVision Advisers first reported a position in EGAN in Q4 2025 and has held it in 2 quarters since. The position peaked at $199K in Q4 2025. 116 funds tracked by Wall St. Rank hold EGAN as of Q1 2026.

  • PharVision Advisers held 10,550 shares of eGain worth $83.2K as of Q1 2026.
  • PharVision Advisers sold 8,825 eGain shares in Q1 2026, an estimated $85.2K.
  • eGain made up 0.84% of PharVision Advisers's portfolio in Q1 2026, its #61 holding.
  • PharVision Advisers first reported a position in eGain in Q4 2025 and has held it in 2 quarters since.
  • PharVision Advisers's eGain position peaked at $199K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held eGain as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.